FR940617-0-00057 FR940617-0-00008 21 CFR Part 510 Animal Drugs, Feeds, and Related Products; Change of Sponsor Name AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor name from Anaquest, Inc., A Subsidiary of BOC Health Care, Inc., to Ohmeda Pharmaceutical Products Division Inc. EFFECTIVE DATE: June 17, 1994. FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for Veterinary Medicine (HFV&hyph;130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1646. SUPPLEMENTARY INFORMATION: Anaquest, Inc., A Subsidiary of BOC Health Care, Inc., Liberty Corner, NJ 07938&hyph;0804, has informed FDA of a change of sponsor name from Anaquest, Inc., A Subsidiary of BOC Health Care, Inc., to Ohmeda Pharmaceutical Products Division Inc. Accordingly, FDA is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change of sponsor name. List of Subjects in 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: PART 510_NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721, of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e). ยง510.600 [Amended] 2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for ``Anaquest, Inc., A Subsidiary of BOC Health Care, Inc.'' and by alphabetically adding a new entry for ``Ohmeda Pharmaceutical Products Division Inc., Liberty Corner, NJ 07938&hyph;0804.....010019''; and in the table in paragraph (c)(2) in the entry for ``010019'' by removing the sponsor name ``Anaquest, Inc., A Subsidiary of BOC Health Care, Inc.'' and by adding in its place ``Ohmeda Pharmaceutical Products Division Inc.'' Dated: June 9, 1994. Robert C. Livingston, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 94&hyph;14709 Filed 6&hyph;16&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
